Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
06/1999
06/10/1999WO1999027923A1 Agents for combating neospora spec
06/10/1999WO1999027906A1 Long acting injectable formulations containing hydrogenated castor oil
06/10/1999WO1999027793A2 An antimicrobial composition
06/10/1999DE19754298A1 Organisch-chemische Verbindungen und Verfahren zu ihrer Herstellung Organic chemical compounds and methods for their preparation
06/10/1999DE19753504A1 Mittel zur Bekämpfung von Neospora spec Means of combating Neospora spec
06/10/1999CA2312396A1 Agents for combating neospora spec
06/09/1999EP0920317A1 Orally applicable formulation of quinolone or naphthyridone carboxylic acids
06/09/1999EP0920311A1 Parenteral paclitaxel in a stable non-toxic formulation
06/03/1999WO1999012951A8 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918756A1 Parasiticidal pyrazoles
06/02/1999EP0918517A1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against parasitary diseases of animals
06/02/1999EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences
06/02/1999CN1218410A Use of IL-12 and IFN-'alpha' for treatment of infections diseases
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
05/1999
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917472A1 Antiprotozoal composition
05/26/1999EP0917465A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same
05/26/1999EP0817769B1 Borneol esters, process for their preparation and their pharmaceutical use
05/26/1999CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
05/26/1999CN1217187A Anti-parasite oral spray containing evericin and ivermectin for sheep
05/20/1999WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus
05/19/1999EP0915977A1 B. burgdorferi polypeptides expressed in vivo
05/19/1999EP0915887A1 Substituted n-isothiazolyl-(thio)amides
05/19/1999EP0915857A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals
05/19/1999EP0915705A1 Ionic polymers as anti-infective agents
05/19/1999CN1216994A Apoptosis inducing molecule II
05/19/1999CN1216920A Acyl urea compounds for treatment of coccidioidomycosis in warmblooded animals
05/19/1999CN1216702A Compound prothiphenyl imidazole emulsion for repelling and curing animal endoparasites and ectoparasite, and method for preparing same
05/14/1999WO1999022761A1 Conjugate heat shock protein-binding peptides
05/14/1999WO1999022727A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
05/14/1999CA2308299A1 Conjugate heat shock protein-binding peptides
05/12/1999EP0914150A1 Recombinant neospora antigens and their uses
05/12/1999EP0914142A1 Peptides with increased binding affinity for hla molecules
05/12/1999EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
05/12/1999EP0722454B1 Stable solvates of avermectin compounds
05/12/1999CN1216584A Immunity to trypanosomatids species
05/12/1999CN1216549A Antipathogenic peptides and compositions comprising them
05/12/1999CN1216470A DHEA combination therapy
05/11/1999CA1340538C Recombinant coccidiosis vaccines
05/06/1999EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912167A1 Granulates of hexahydropyrazine derivatives which can be administered orally
05/05/1999CN1215590A Albendazole suspension for expelling and controlling parasite in livestock, and preparing process thereof
05/04/1999US5900431 Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections
05/04/1999US5900430 Cytokine inhibitors
04/1999
04/29/1999WO1999020303A1 Neospora vaccines
04/29/1999CA2306642A1 Neospora vaccines
04/28/1999EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid
04/28/1999EP0910633A2 Polyketides and their synthesis
04/28/1999EP0910574A2 Method for discovering novel anthelmintic compounds
04/28/1999EP0910406A1 Recombinant canine herpesviruses
04/28/1999CN1215407A Human antibodies that bind huma TNF 'alpha'
04/28/1999CN1215332A Use of subsitituted aryl imidazoles
04/28/1999CN1043142C Quinolone and naphthyridone-carboxylic acid derivatives and preparation process
04/22/1999WO1999019338A1 Inhibitors of nucleoside metabolism
04/22/1999WO1999018975A1 Leishmaniasis remedy containing glucopyranose derivative as the active ingredient
04/22/1999WO1999001136A9 Novel substituted imidazole compounds
04/21/1999EP0909327A2 Erythromycins and process for their preparation
04/21/1999CN1214630A Photopheresis treatment of leukocytes
04/20/1999CA2165806C Antiparasitic agents
04/20/1999CA2138447C Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, virus or protozoan infections as well as for immunomodulation
04/14/1999EP0907732A2 Polynucleotides encoding secreted proteins
04/14/1999EP0907373A1 Use of il-12 and ifn-alpha for the treatment of infectious diseases
04/14/1999EP0907363A1 8-aminoquinolines
04/13/1999CA2173494C Process and antiparasitic intermediates for doramectin
04/13/1999CA2143216C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
04/13/1999CA2110437C 15-deoxysperqualin analogs, their method of preparation and their use in therapeutics
04/08/1999WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response
04/07/1999CN1213307A Novel substituted imidazolium compounds
04/01/1999WO1999015166A1 Parasiticidal formulations
04/01/1999CA2304283A1 Parasiticidal formulations
03/1999
03/31/1999EP0904291A2 Antipathogenic peptides and compositions comprising them
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999CN1212256A Quinolone-and naphthyridone-carboxylic acid derivatives
03/31/1999CN1212154A Drug for curing infectious disease of fowl
03/30/1999US5889166 Recombinant neospora antigens and their uses
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889007 Chemisensitizing agents; cancer therapy drug resistance
03/30/1999US5888518 Method for preventing and treating coccidiosis
03/30/1999CA2168731C Antiparasitic agents
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014339A1 ASPARAGINASE PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF OBTAINABLE FROM A PARASITIC HELMINTH, IN PARTICULAR FROM $i(DIROFILARIA IMMITIS)
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/24/1999CN1211985A Fused imidazole derivatives as multidrug resistance modulators
03/23/1999US5886180 25-methylene and 24-25 -epoxy marcfortines and paraherquamides
03/23/1999US5886179 Nucleotide analogs
03/23/1999US5885814 Vaccine containing a serine protease
03/23/1999US5885568 Coccidiosis poultry vaccine
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012951A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
03/18/1999WO1999012565A1 Vaccines
03/18/1999WO1999012554A1 Chemical supplementation of bone
03/18/1999CA2303422A1 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999CA2303347A1 Chemical supplementation of bone
03/18/1999CA2302687A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 218